We're Officially Research Subjects Now

noteablequotable

noteablequotable

Research Enthusiast
Joined
Sep 28, 2024
Messages
440
Reaction score
1,463
Location
United States
noteablequotable said:
The Role of Online Communities in Facilitating Access to Non-Pharmacy Provided Tirzepatide for Weight Loss: A Growing Trend

The Role of Online Communities in Facilitating Access to Non-Pharmacy Provided Tirzepatide for Weight Loss: A Growing Trend

The Role of Online Communities in Facilitating Access to Non-Pharmacy Provided Tirzepatide for Weight Loss: A Growing ...
jeremy-ideas.blogspot.com jeremy-ideas.blogspot.com

Long and a bit repetitive, but still interesting.
Click to expand...
Ehhh. It’s a very chatgpt-formatted blogspot post with section 9, References, just left blank. Not sure I’d call it a research paper, it certainly isn’t getting published. It’s on par with those council of harm reduction “whitepapers.” That guy is definitely in the servers though.
 
exploitedworkerbee said:
Ehhh. It’s a very chatgpt-formatted blogspot post with section 9, References, just left blank. Not sure I’d call it a research paper, it certainly isn’t getting published. It’s on par with those council of harm reduction “whitepapers.” That guy is definitely in the servers though.
Click to expand...

Yeah there are lots of problems with it. They're making simple mistakes like calling Tirzepatide use for weight loss "off label" when that's not factually true now that Lilly sells Zepbound. No one knowledgeable who was expecting peer review would make that mistake.

It's definitely a pretend academic (possibly AI written) article.
 
noteablequotable said:
Yeah there are lots of problems with it. They're making simple mistakes like calling Tirzepatide use for weight loss "off label" when that's not factually true now that Lilly sells Zepbound. No one knowledgeable who was expecting peer review would make that mistake.

It's definitely a pretend academic (possibly AI written) article.
Click to expand...
My guess based on the author’s website is he is angling to establish himself as a subject matter expert for his pharma consulting firm. Maybe get some of that sweet sweet Lilly cash explaining to them the ins and outs of the market they’d like to see shut down?
 
exploitedworkerbee said:
Ehhh. It’s a very chatgpt-formatted blogspot post with section 9, References, just left blank. Not sure I’d call it a research paper, it certainly isn’t getting published. It’s on par with those council of harm reduction “whitepapers.” That guy is definitely in the servers though.
Click to expand...
Perhaps this peprat removed the sources before publishing online so they couldn't be checked or cross-referenced to prevent finding out who he is on those servers?
 
exploitedworkerbee said:
My guess based on the author’s website is he is angling to establish himself as a subject matter expert for his pharma consulting firm. Maybe get some of that sweet sweet Lilly cash explaining to them the ins and outs of the market they’d like to see shut down?
Click to expand...

Oh, why didn't I think of that. I could use some of those sweet Lilly bucks.

I wonder how long I could feed them useless Chat GPT summaries before they stop paying me?
 
i can believe there's an ai contribution here, but it's interesting nonetheless. the first thing that jumped out at me is the author's location in indianapolis, indiana. that's where eli lilly is HQ. but i looked him up and couldn't find any overt connection to lilly. however he does have a strong pharma academic background.

the paper is interesting, i'm not sure what the intention is, is he just explaining the state of the market for some client?

one thing i found to nitpick is:
The legality of purchasing Tirzepatide from non-pharmacy sources is complex and varies by jurisdiction. In many countries, including the United States, Tirzepatide is classified as a prescription-only medication, meaning that purchasing it without a valid prescription is illegal. While non-pharmacy suppliers, particularly those based in countries like China, operate in legal gray areas where the regulation of peptide sales may be more lax, the individuals who purchase these products in countries with stricter regulations are often violating local laws.
Click to expand...

i'm not clear on this. my understanding is it's technically legal to purchase "research peptides" and the only real legal issue with buying it from china is that it's not properly declared with customs. i understand that there is a clear delineation here between a research pep like tirz and a controlled substance like an anabolic steroid. who's right here?
 
also find that he cribs heavily from the guides on reddit, mostly contributed by @stairmaster , that user is the one who strongly recommends only using hospira bac, avoiding vendor group buys, and ignoring vendor COAs. also provides guidance on splitting name brand pen dosage which is a stairmaster1 specialty.

this guy is reading the tirzepatidehelp reddit and just reformatting it in a doc, or maybe his gpt did it
 
clayd said:
i can believe there's an ai contribution here, but it's interesting nonetheless. the first thing that jumped out at me is the author's location in indianapolis, indiana. that's where eli lilly is HQ. but i looked him up and couldn't find any overt connection to lilly. however he does have a strong pharma academic background.

the paper is interesting, i'm not sure what the intention is, is he just explaining the state of the market for some client?

one thing i found to nitpick is:


i'm not clear on this. my understanding is it's technically legal to purchase "research peptides" and the only real legal issue with buying it from china is that it's not properly declared with customs. i understand that there is a clear delineation here between a research pep like tirz and a controlled substance like an anabolic steroid. who's right here?
Click to expand...
Yeah chatgpt definitely isn’t fully responsible for the content, but it almost certainly played a big part in the editing.

Regarding the purchasing of our dear compounds, they’re patented molecules so it’s a violation of IP laws to import them, hence all the crossover this community has with the bootlegged purse ladies. The anabolic stuff runs afoul of different, more serious laws
 
exploitedworkerbee said:
Yeah chatgpt definitely isn’t fully responsible for the content, but it almost certainly played a big part in the editing.

Regarding the purchasing of our dear compounds, they’re patented molecules so it’s a violation of IP laws to import them, hence all the crossover this community has with the bootlegged purse ladies. The anabolic stuff runs afoul of different, more serious laws
Click to expand...
i haven't spent a lot of time looking into this stuff so i plead ignorance but i was unaware it's a vioation to import tirz because of patent. would like to understand this more. i'll do some research but if anyone has a quick and handy link, please do send.
 
clayd said:
i haven't spent a lot of time looking into this stuff so i plead ignorance but i was unaware it's a vioation to import tirz because of patent. would like to understand this more. i'll do some research but if anyone has a quick and handy link, please do send.
Click to expand...
www.uspto.gov

Managing a patent

This introduction to managing a patent describes the nature of patent rights, factors to consider when managing your U.S. patent after it’s issued, and how a patent can be infringed.
www.uspto.gov www.uspto.gov

“Patent infringement consists of “unauthorized making, using, offering for sale, or selling any patented invention within the United States, or importing into the United States any patented invention during its term.” You the patent owner may sue in federal court to stop the infringement and ask for financial damages.”
 
exploitedworkerbee said:
My guess based on the author’s website is he is angling to establish himself as a subject matter expert for his pharma consulting firm. Maybe get some of that sweet sweet Lilly cash explaining to them the ins and outs of the market they’d like to see shut down?
Click to expand...
Maybe he already works for LLY (or provided this project on a contract payment) and published the seemingly “independent” paper as bait for the FDA. I’m sure LLY is considering all kinds of methods intended to deter gray market GLP1s.
 
exploitedworkerbee said:
Yeah chatgpt definitely isn’t fully responsible for the content, but it almost certainly played a big part in the editing.

Regarding the purchasing of our dear compounds, they’re patented molecules so it’s a violation of IP laws to import them, hence all the crossover this community has with the bootlegged purse ladies. The anabolic stuff runs afoul of different, more serious laws
Click to expand...
Yeah. The frequent word-for-word repetition is a pretty major hallmark of LLM generation.

I wouldn't be surprised if a bunch of different things were copy-pasted into ChatGPT with the prompt of "Turn these into a research paper", heh.
 
He has another article about his personal experience (recent) with Zepbound on LinkedIn, dated 1 day after the above blog post. He is not a good writer as I could clearly see the transitions between his writing and ChatGPT/LLM (areas of interest). Ironically, he uses the word “Zepbound” but describes what appears to me as the medspa/compounding pharmacy process.

Who knows, he may end up here looking for grey market help.
 
You must log in or register to reply here.

Trending content

Latest posts

Members online

Total: 16 (members: 6, guests: 10)

Forum statistics

Threads
1,981
Messages
32,987
Members
3,600
Latest member
Qizheng Melody

Share this page

Back
Top